Combination of bifunctional alkylating agent and arsenic trioxide synergistically suppresses the growth of drug-resistant tumor cells. [electronic resource]
Producer: 20100813Description: 376-87 p. digitalISSN:- 1476-5586
- Animals
- Antineoplastic Agents, Alkylating -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis
- Arsenic Trioxide
- Arsenicals -- administration & dosage
- Blotting, Western
- Carbamates -- administration & dosage
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Separation
- Drug Resistance, Neoplasm -- drug effects
- Drug Synergism
- Flow Cytometry
- Fluorescent Antibody Technique
- Heterocyclic Compounds, 3-Ring -- administration & dosage
- Humans
- Immunohistochemistry
- In Situ Nick-End Labeling
- Male
- Mice
- Mice, Nude
- Neoplasms, Experimental -- drug therapy
- Oxides -- administration & dosage
- Signal Transduction -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.